Update on the Epidemiology of Multiple Sclerosis

Mayo Clinic Proceedings

Volumn 64, Issue 7, 1989, Pages 808-817

  WYNN, DANIEL R ^a   RODRIGUEZ, MOSES ^a   O'FALLON, W MICHAEL ^b   KURLAND, LEONARD T ^c  

^a Department of Neurology ^*

^b Section of Biostatistics ^*

^c Section of Clinical Epidemiology ^*

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVIEW;

EID: 0024453006     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-6196(12)61754-6     Document Type: Article

References (126)

1. Multiple sclerosis from the standpoint of geographic distribution and race
2. Die multiple Sklerose in der Nordwest-schweiz
3. Die multiple Sklerose in der Schweiz: Enquete von 1918–22
4. Disseminated sclerosis in North Wales: an inquiry into its incidence, frequency, distribution and other etiological factors
5. Multiple sclerosis. I. The etiological significance of the regional and occupational incidence
6. The geographic distribution of multiple sclerosis and its estimated prevalence in the United States
7. The epidemiologic characteristics of multiple sclerosis
8. Epidemiology of multiple sclerosis
9. Multiple sclerosis in a rural community
10. Multiple sclerosis in Rochester, Minn: a 60-year appraisal
11. Multiple sclerosis in Olmsted and Mower Counties, Minnesota
12. Multiple sclerosis in Olmsted County: an 80-year review (abstract)
13. Multiple sclerosis in the Orkney and Shetland Islands. I. Epidemiology, clinical factors, methodology
14. New diagnostic criteria for multiple sclerosis: guidelines for research protocols
15. Descriptive epidemiology of multiple sclerosis in Italy
16. Contribution to the incidence of multiple sclerosis among Jews in Israel
17. Multiple sclerosis in Israel: prevalence among immigrants and native inhabitants
18. Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa
19. Evidence for lower susceptibility to multiple sclerosis among Japanese-Americans
20. Latitude, migration, and the prevalence of multiple sclerosis
21. Multiple sclerosis in a migrant population. 2. Half-orientals immigrating in childhood
22. Migration and risk of multiple sclerosis
23. Multiple sclerosis and age at migration
24. Motor neurone disease and multiple sclerosis among immigrants to Britain
25. MS in Hungary, including the Gipsy population
26. Multiple sclerosis in the Faroe Islands. I. Clinical and epidemiological features
27. Multiple sclerosis in the Faroe Islands. II. Clinical update, transmission, and the nature of MS
28. MS epidemiology in Faroe Islands
29. The epidemiology of multiple sclerosis
30. Viral aspects of multiple sclerosis
31. Measles antibodies in multiple sclerosis
32. Multiple sclerosis and age at exposure to childhood diseases and animals: cases and their friends
33. Virus antibodies in serum specimens from patients with multiple sclerosis, from siblings, and matched controls: a final report
34. Multiple sclerosis and childhood infections
35. Does delay in acquiring childhood infection increase risk of multiple sclerosis? (editorial)
36. Multiple sclerosis in the Orkney and Shetland Islands. IV. Viral antibody titres and viral infections
37. Multiple sclerosis and dogs (letter to the editor)
38. A possible association between house pets and multiple sclerosis
39. Further evidence of a possible association between house dogs and multiple sclerosis
40. Distemper and multiple sclerosis in Sitka, Alaska
41. MS in Iceland revisited (letter to the editor)
42. Declining incidence of multiple sclerosis in the Orkney Islands
43. Multiple sclerosis and canine distemper on Key West, Florida (letter to the editor)
44. Experimental canine distemper virus-induced demyelination
45. Cerebrospinal fluid gamma globulins in canine distemper encephalitis
46. Canine distemper virus
47. Multiple sclerosis and house dogs: a case control study
48. House pets and multiple sclerosis (letter to the editor)
49. The association of multiple sclerosis with domestic animals and household pets
50. Pet ownership, distemper antibodies and multiple sclerosis
51. Multiple sclerosis and dog ownership: a case-control investigation
52. Antibody responses to measles virus and canine distemper virus in multiple sclerosis
53. Multiple sclerosis and canine pets
54. Clinical viral infections and multiple sclerosis
55. Multiple sclerosis associated with sinusitis: case-controlled study in general practice
56. Seasonal variation of multiple sclerosis exacerbations in Arizona
57. Multiple sclerosis and the local weather
58. The seasonal incidence of onset and exacerbations in multiple sclerosis
59. The etiology and pathogenesis of multiple sclerosis
60. Infection and immunization in multiple sclerosis
61. Seasonal variation in multiple sclerosis and retrobulbar neuritis in northeastern Ohio
62. The seasonal incidence of multiple sclerosis in Switzerland
63. Multiple sclerosis and childhood infections
64. Tabes und multiple Sklerose in ihren Beziehungen zum Trauma
65. The problem of disseminated sclerosis
66. Early clinical manifestations of disseminated sclerosis
67. Twin study of multiple sclerosis: an epidemiologic inquiry
68. Trauma as an etiologic and aggravating factor in multiple sclerosis
69. Epidemiologic factors in the etiology and prognosis of multiple sclerosis
70. The association of cervical spondylosis and disseminated sclerosis
71. The cervical cord in multiple sclerosis
72. La perméabilité des vaisseaux cérébraux. VI. Démyélinisation expérimentale provoquée par des substances agissant sur la barrière hémato-encéphalique
73. Pathologic-anatomical findings and cerebral localization in stereotactic treatment of extrapyramidal motor disturbances in multiple sclerosis
74. Trauma and multiple sclerosis: an hypothesis
75. Multiple sclerosis and the workplace: report of an industry-based cluster
76. The risk of multiple sclerosis in Denmark
77. The incidence and prevalence of reported multiple sclerosis
78. Monocyte-dependent stimulation of human T cells by zinc
79. Excessive intake of zinc impairs immune responses
80. Clinical, biochemical and pharmacological role of zinc
81. Zinc in multiple sclerosis. II. Correlation with disease activity and elevated plasma membrane-bound zinc in erythrocytes from patients with multiple sclerosis
82. Disease of the nervous system occurring among research workers on swayback in lambs
83. Chronic neurological disease as a possible form of lead poisoning
84. Multiple sclerosis clustering in a small Massachusetts community, with possible common exposure 23 years before onset
85. Multiple sclerosis: a cluster in a small northwestern United States community
86. An unusual occurrence of multiple sclerosis in a small rural community
87. Multiple sclerosis in a small New England community
88. Endemic clustering of multiple sclerosis in time and place, 1934–1984: confirmation of a hypothesis
89. Multiple sclerosis: a correlation of its incidence with dietary fat
90. Multiple sclerosis in rural Norway
91. Diet and the geographical distribution of multiple sclerosis
92. Diet and geographic distribution of multiple sclerosis (letter to the editor)
93. Studies on multiple sclerosis in Winnipeg, Manitoba, and New Orleans, Louisiana. I. Prevalence: comparison between the patient groups in Winnipeg and New Orleans
94. Dietetic and related studies on multiple sclerosis
95. Treatment of multiple sclerosis with fat-soluble vitamins: animal fat and ammonium chloride
96. Multiple sclerosis: a population-based investigation of the association with possible autoimmune diseases and diabetes mellitus (abstract)
97. Multiple sclerosis: a population-based investigation of the association with neoplastic disorders (abstract)
98. Multiple sclerosis and autoimmune diseases
99. Multiple sclerosis and autoimmune diseases
100. The occurrence of myasthenia gravis in a patient with multiple sclerosis
101. Myasthenia gravis and multiple sclerosis: an unusual combination of diseases
102. Multiple sclerosis and myasthenia gravis: a case report with single fiber electromyography
103. Myasthenia gravis and multiple sclerosis
104. Antinuclear antibodies in multiple sclerosis
105. The neurological complications of ankylosing spondylitis
106. Ankylosing spondylitis and multiple sclerosis: a possible association
107. Nervous system involvement in ankylosing spondylitis
108. Sclérose en plaques et maladie lupique
109. A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus
110. Systemic lupus erythematosus and multiple sclerosis in identical twins
111. Systemic sclerosis (scleroderma) and multiple sclerosis
112. Malignant diseases among patients with multiple sclerosis
113. Multiple cerebral gliomas in multiple sclerosis
114. Multiple sclerosis and malignant neoplasms of the central nervous system
115. Multiple sclerosis and associated diseases: a relationship to diabetes mellitus
116. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality
117. Epidemiologic aspects of Hashimoto's thyroiditis and Graves' disease in Rochester, Minnesota (1935–1967), with special reference to temporal trends
118. Diabetes mellitus: incidence, prevalence, survivorship, and causes of death in Rochester, Minnesota, 1945–1970